| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: XTNT |
| Security Type |
Common Stock |
| Lead Underwriter |
Piper Jaffray Cos |
| Days In Registration |
177 |
| Date Filed |
7-Aug-2006 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
XTENT Inc, located in Menlo Park, California, is a manufacturer of medical devices, focused on developing customizable drug eluting stent systems for the treatment of coronary artery diseases. The company was founded in 2002. |
| Revenue |
- |
| Net Income |
-$28.9M |
| Shares Outstanding (post-offering) |
22.8M |
| Contact |
- |
| Number of Employees |
127 |
|
| Original Filing Information |
| US |
| Shares Filed |
4.7M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
4.7M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
705.0K |
| File Amount |
$79.9M |
| File Price Range |
$18.00 - $16.00 |
| File Mid Price |
$17.00 |
Current Filing Information
(Amended 30-Jan-2007) |
|
US |
|
Shares Filed |
4.7M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
4.7M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$79.9M |
| · % Change from Original |
0.0 |
| File Price Range |
$18.00 - $16.00 |
| File Mid Price |
$17.00 |
|
